BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33767586)

  • 1. AKR1B10 confers resistance to radiotherapy via FFA/TLR4/NF-κB axis in nasopharyngeal carcinoma.
    Liu X; Hu Z; Qu J; Li J; Gong K; Wang L; Jiang J; Li X; He R; Duan L; Luo W; Xia C; Luo D
    Int J Biol Sci; 2021; 17(3):756-767. PubMed ID: 33767586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
    Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
    J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low expression of Aldo-keto reductase 1B10 is a novel independent prognostic indicator for nasopharyngeal carcinoma.
    Guo Y; Luo W; Hu Z; Li J; Li X; Cao H; Li J; Wen B; Zhang J; Cheng H; Guo W; Tan T; Luo D
    Cell Biosci; 2016; 6():18. PubMed ID: 26949513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma.
    Di M; Wang M; Miao J; Chen B; Huang H; Lin C; Jian Y; Li Y; Ouyang Y; Chen X; Wang L; Zhao C
    Biomed Pharmacother; 2020 Mar; 123():109748. PubMed ID: 31869663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway.
    Nie X; Guo E; Wu C; Liu D; Sun W; Zhang L; Long G; Mei Q; Wu K; Xiong H; Hu G
    Cancer Med; 2019 Apr; 8(4):1779-1792. PubMed ID: 30907073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Homologous Recombination Repair Pathway is Associated with Resistance to Radiotherapy in Nasopharyngeal Carcinoma.
    Wang Z; Zuo W; Zeng Q; Li Y; Lu T; Bu Y; Hu G
    Int J Biol Sci; 2020; 16(3):408-419. PubMed ID: 32015678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy.
    Tan Z; Xiao L; Tang M; Bai F; Li J; Li L; Shi F; Li N; Li Y; Du Q; Lu J; Weng X; Yi W; Zhang H; Fan J; Zhou J; Gao Q; Onuchic JN; Bode AM; Luo X; Cao Y
    Theranostics; 2018; 8(9):2329-2347. PubMed ID: 29721083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance by Targeting A20/NF-κB Signaling Pathway.
    Li LN; Xiao T; Yi HM; Zheng Z; Qu JQ; Huang W; Ye X; Yi H; Lu SS; Li XH; Xiao ZQ
    Mol Cancer Ther; 2017 Oct; 16(10):2094-2106. PubMed ID: 28698199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FBP1 enhances the radiosensitivity by suppressing glycolysis via the FBXW7/mTOR axis in nasopharyngeal carcinoma cells.
    Zhang P; Shao Y; Quan F; Liu L; Yang J
    Life Sci; 2021 Oct; 283():119840. PubMed ID: 34298040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA CASC19 Contributes to Radioresistance of Nasopharyngeal Carcinoma by Promoting Autophagy via AMPK-mTOR Pathway.
    Liu H; Zheng W; Chen Q; Zhou Y; Pan Y; Zhang J; Bai Y; Shao C
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV encoded miRNA BART8-3p promotes radioresistance in nasopharyngeal carcinoma by regulating ATM/ATR signaling pathway.
    Zhou X; Zheng J; Tang Y; Lin Y; Wang L; Li Y; Liu C; Wu D; Cai L
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31471531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.
    Qu C; Zhao Y; Feng G; Chen C; Tao Y; Zhou S; Liu S; Chang H; Zeng M; Xia Y
    J Cell Mol Med; 2017 Nov; 21(11):2872-2883. PubMed ID: 28557284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of AKR1B10 in nasopharyngeal carcinoma as a potential biomarker.
    He YC; Shen Y; Cao Y; Tang FQ; Tian DF; Huang CF; Tao H; Zhou FL; Zhang B; Song L; He L; Lin LM; Lu FG; Liao DF; Cao D
    Cancer Biomark; 2016; 16(1):127-35. PubMed ID: 26835713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of livin overcomes radioresistance in nasopharyngeal carcinoma cells.
    Ma F; Gu X; Liu JQ; Mo LH; Yang G; Geng XR; Liu ZQ; Liu ZG; Yang PC
    PLoS One; 2020; 15(3):e0229272. PubMed ID: 32119704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of phosphorylated Raf kinase inhibitory protein at serine 153 and its predictive effect on the clinical response to radiotherapy in nasopharyngeal carcinoma.
    Li S; Liu T; Mo W; Hou Q; Zhou Y; Liu M; He Z; Liu Z; Chen Q; Wang H; Guo X; Xia W; Zeng M; Zhao H
    Radiat Oncol; 2016 Sep; 11(1):121. PubMed ID: 27647315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of annexin VII enhances nasopharyngeal carcinoma cell radiosensitivity in vivo and in vitro.
    Gui SJ; Ding RL; Wan YP; Zhou L; Chen XJ; Zeng GQ; He CZ
    Cancer Biomark; 2020; 28(2):129-139. PubMed ID: 31958076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeic acid phenethyl ester suppressed growth and metastasis of nasopharyngeal carcinoma cells by inactivating the NF-κB pathway.
    Liang Y; Feng G; Wu L; Zhong S; Gao X; Tong Y; Cui W; Qin Y; Xu W; Xiao X; Zhang Z; Huang G; Zhou X
    Drug Des Devel Ther; 2019; 13():1335-1345. PubMed ID: 31118570
    [No Abstract]   [Full Text] [Related]  

  • 18. VEGF knockdown enhances radiosensitivity of nasopharyngeal carcinoma by inhibiting autophagy through the activation of mTOR pathway.
    Chen L; Lin G; Chen K; Wan F; Liang R; Sun Y; Chen X; Zhu X
    Sci Rep; 2020 Oct; 10(1):16328. PubMed ID: 33004943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokeratin 13 promotes radiotherapy sensitivity of nasopharyngeal carcinoma by downregulating the MEK/ERK pathway.
    Shi M; Wan J; Wang H; Yu H
    IUBMB Life; 2022 Jun; 74(6):543-553. PubMed ID: 35426961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homeobox A5 activates p53 pathway to inhibit proliferation and promote apoptosis of adrenocortical carcinoma cells by inducing Aldo-Keto reductase family 1 member B10 expression.
    Chen D; Shen Z; Cheng X; Wang Q; Zhou J; Ren F; Sun Y; Wang H; Huang R
    Bioengineered; 2021 Dec; 12(1):1964-1975. PubMed ID: 34027794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.